Marinus Pharmaceuticals' patent battle with New York firm over seizure therapy takes new twist

“As a company grounded in scientific research, we will vigorously defend our patents,” said Marinus CEO Dr. Scott Braunstein.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2024 Category: Pharmaceuticals Authors: John George Source Type: news